Stay updated on Nivolumab and Ipilimumab in ACC Clinical Trial

Sign up to get notified when there's something new on the Nivolumab and Ipilimumab in ACC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab and Ipilimumab in ACC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    A site-wide notice says NIH is transitioning from using “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T01:48:09.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.1 to v3.7.2 while the page continued to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-18T01:33:13.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1 on the 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-11T02:06:44.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    The study page renders a 403 Forbidden error instead of the usual content, replacing the study details and links with an access-denied message. This indicates a gating of the study record, hindering user access to the trial information.
    Difference
    21%
    Check dated 2026-09-20T01:06:24.000Z thumbnail image
  5. Check
    63 days ago
    Change Detected
    Summary
    The page shows a revision tag update from v3.6.5 to v3.6.6, indicating a platform version upgrade. No study content or visible functionality appear to be altered.
    Difference
    0.1%
    Check dated 2026-08-29T19:47:46.000Z thumbnail image
  6. Check
    84 days ago
    Change Detected
    Summary
    The page's revision label has been updated from v3.6.4 to v3.6.5. This indicates a minor update to the page's build or documentation.
    Difference
    0.0%
    Check dated 2026-08-08T11:01:14.000Z thumbnail image

Stay in the know with updates to Nivolumab and Ipilimumab in ACC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab and Ipilimumab in ACC Clinical Trial page.